Literature DB >> 6299235

Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses.

A Garcá Gancedo, C Gil-Fernández, P Vilas, S Perez, E Paez, F Rodriguez, M F Braña, C M Roldán.   

Abstract

The antiviral action of a new drug, 5-amino-2-(dimethylaminoethyl)-benzo-[de]-isoquinolin-1.3-dione has been studied against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5) grown in Vero cells. The concentration of the drug which gives a 5 log10 reduction in virus titer was 4 micrograms/ml (maximum tolerated concentration) for HSV-2. The anti-HSV-2 activity of this compound was one log. more powerful than that of iododeoxyuridine (IDU). At this concentration the drug shows virucidal activity against HSV-2. No inhibition was found when the drug was tested against Ad-5. The inhibition of virus production has been studied depending upon the amount of drug or virus, and drug addition-time after infection. Reversibility of inhibition after drug removal, and drug resistance in the presence of the drug have also been determined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299235     DOI: 10.1007/bf01314709

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  5 in total

1.  Plaque assay in petri dishes in the absence of CO2 atmosphere.

Authors:  C Ronda-Lain; C Gil-Fernandez
Journal:  Microbiol Esp       Date:  1970 Jan-Mar

2.  Intercalative binding to DNA of antitumour drugs derived from 3-nitro-1,8-naphthalic acid.

Authors:  M J Waring; A González; A Jiménez; D Vázquez
Journal:  Nucleic Acids Res       Date:  1979-09-11       Impact factor: 16.971

3.  Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.

Authors:  E De Clercq; J Descamps; G Verhelst; R T Walker; A S Jones; P F Torrence; D Shugar
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

4.  Antiviral action of benzo[de]isoquinoline-1,3-diones: 5-nitro-2-(2-dimethylaminoethyl) and 5-nitro-2-[2-(1-pyrrolidine)-ethyl] derivatives.

Authors:  A García-Gancedo; C Gil; C M Roldán; S Pérez; P Vilas
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

5.  Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.

Authors:  M F Braña; J M Castellano; C M Roldán; A Santos; D Vázquez; A Jiménez
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

  5 in total
  3 in total

1.  In vitro activity of amonafide against primary human tumors compared with the activity of standard agents.

Authors:  J A Ajani; F L Baker; G Spitzer
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850

2.  Phase II study of amonafide in advanced pancreatic adenocarcinoma.

Authors:  K Linke; R Pazdur; J L Abbruzzese; J A Ajani; R Winn; J E Bradof; K Daugherty; B Levin
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

3.  Synthesis, FTIR, ¹³C-NMR and temperature-dependent ¹H-NMR characteristics of bis-naphthalimide derivatives.

Authors:  Waldemar Grzesiak; Bogumił Brycki
Journal:  Molecules       Date:  2012-10-22       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.